Brandon Buck: Human Cell-Free DNA as a Diagnostic Tool for Aging and Rare Blood Disorders
Brandon Buck, Postdoctoral Research Fellow at Harvard Medical School, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nature Progress Oncology, adding:
“Officially published my first-author Ph.D. manuscript on utilizing human blood plasma cell free DNA as a diagnostic tool for analyzing the telomeric and genomic landscape in aging and rare blood disorders.
Additionally, cell free DNA reveals unique telomeric chromatin footprints in vivo.
After numerous years of coding, data analysis, Illumina and Oxford Nanopore sequencing, CUTandRUN experiments, and cell free DNA isolations and library preps, the paper has been published, and a provisional patent has been submitted.
Please enjoy!”
Title: Fragmentation patterns of human telomeric chromatin in plasma cfDNA
Authors: Brandon Buck, Abigail Weirich, Stephanie Eramo, Rachel Lopez, Laura K. White, Peter Kabos, Craig Forester, Srinivas Ramachandran 
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice
-
Oct 21, 2026, 16:19Vanessa Carvalho: New Research on Platelet-Derived Extracellular Vesicles in Preeclampsia
-
Oct 21, 2026, 15:41Women and Hemostasis Across Hormonal Transition
-
Oct 21, 2026, 15:35Danny Hsu: Pharma’s 2025 Blockbusters Through a Hematologist’s Lens
-
Oct 21, 2026, 15:12Yue Zhang: Flow Cytometry for Translational Immunology and Cancer Research
-
Oct 21, 2026, 14:58Radoš Stefanović: How Red Blood Cells Adapt After Exercise
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders